The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.25 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Tue, 31st Aug 2021 21:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Jet2 PLC - Yeadon, England-based airline and package holiday operator - Enters into deal with Airbus SE to buy 36 new Airbus A321 neo aircrafts. Deal includes flexbility to boost order by up to 60 aircrafts. At current list prices, order has total value of USD4.9 billion, with total transaction value for up to 60 aircraft of roughly USD8.1billion. Jet2 adds: "The company has negotiated significant discounts from the list price. The company will retain flexibility in determining the most favourable method of financing the aircraft, which will be through a combination of internal resources and debt."

----------

Strix Group PLC - Isle of Man kettle safety controls supplier - Says new facility in hina fully operational. Factory is located in Zengcheng district in Guangzhou. Strix adds: "The new factory will double the group's current manufacturing capacity enabling it to grow the business and deliver its stated strategy of doubling revenues over the next five years. Efficiencies and further in-sourcing arising from the new manufacturing facility are expected to have a positive effect on margins."

----------

Velocys PLC - Oxford, England-based fuels technology company - Partner Toyo Engineering Corp kicks off advanced engineering and design phase of commercial scale biofuel refinery in Japan. During the phase, Toyo will integrate Velocys' Fischer Tropsch technology.

----------

GCM Resources PLC - London-based mining company - Agrees deal with Sion Corp, Versatech Energy Innovation Ltd and AC Biode Co Ltd for suitable and effective environmental management of waste produces by Phulbari coal and power project.

----------

Rambler Metals & Mining PLC - Canada-focused copper and gold producer - Updates on debt financing package from Newgen Resource Lending Inc. Says due diligence completed and parties now working on legal documents, including loan agreement. "The proceeds of this financing will be used to continue funding mine development including contractor development required to set up the Lower Footwall zone, which will support operations for the balance of 2021 into 2022 and beyond, to repay outstanding indebtedness, and to provide additional working capital," Rambler adds.

----------

Jadestone Energy PLC - oil and gas producer in Asia-Pacific region - Working with OMV New Zealand Ltd to seal 69% acquisition of Maari asset in New Zealand. Current longstop date extended past August 31.

----------

88 Energy Ltd - Alaska-focused oil exploration and appraisal company - Proposes placing to raise AUD20 million, about GBP10.6 million. Shares to be placed at AUD0.028. 88 Energy adds: "This net proceeds of the Placing, together with the company's existing cash reserves, will strengthen the company's balance sheet and will provide the company with sufficient capital to finance the drilling and logging of the Merlin-2 appraisal well in Q1 2022, targeting 652 million barrels in the N20, N19 and N18 horizons, fund lease acreage payments and enable identification and execution of potential new project opportunities."

----------

Premier African Minerals Ltd - southern Africa-focused miner - Says existing loan agreement with Otjozondu Mining Pty Ltd to now be funded by Premier African Chair Neil Herbert. "This allows both Premier and Otjozondu to proceed with alternative negotiations intended to improve the existing arrangements and to secure advance funding to support planned expansions in mining operations," Premier African says.

----------

BlueRock Diamonds PLC - owner and operator of Kareevlei diamond mine in South Africa - Says 58.6 carat diamond sold for USD585,000. In addition, company sells a 21.6 carat stone for USD268,000 and a 14.3 carat stones for USD236,000. Executive Chair Mike Houston says: "We are delighted with the price achieved for each of these high-quality diamonds, which brought the total sales proceeds for the August tender to USD2.1 million, far exceeding the previous highest monthly sale of approximately USD900,000. The average price per carat for the whole parcel was approximately USD800."

----------

Beowulf Mining PLC - developing Kallak iron ore project and the Aitolampi natural flake graphite project - Submits concluding comments to Sweden's Ministry of Enterprise & Innovation in regards to UNESCO letter related to Kallak iron ore project. The letter states the Kallak project will not have "direct effects" on Laponian area. Beowulf adds: "The fact that the company has already committed to take precautionary measures that will minimize the impact on reindeer husbandry and commits to fully compensate Saami villages."

----------

Eco Atlantic Oil & Gas Ltd - oil and gas exploration company focused on Guyana and Namibia - Says Sapote-1 well on Canje Block, offshore Guyana has been spudded. Eco holds indirect interest at project through 10% holding in JHI Associates Inc.

----------

Mosman Oil & Gas Ltd - New South Wales, Australia-based exploration & production firm - Says drilling of Winters-2 well in Texas expected to begin a soon as a contracted drill rig is available. Mosman adds: "The rig contractor has advised of the current challenges to secure rig crew due to the ongoing effects of the Covid-19 pandemic in the USA. As soon as a firm drill date has been confirmed, further announcements will be made in regard to the commencement of drilling."

----------

Belluscura PLC - London-based oxygen enrichment technology developer - Welcomes statement from American College of Chest Physicians which advises on rationale for home use of oxygen, beyond cluster headaches. Cluster headaches are severe attacks of pain on one side of head. It follows US Centers for Medicare & Medicaid Services proposing use of oxygen for cluster headaches. Belluscura Chief Executive Robert Rauker says: "This CHEST rationale, following on so closely from the CMS proposals, highlights the expanding demand for home oxygen, and the increasing opportunity for Belluscura's novel oxygen concentrator technology. Shareholders will be kept fully updated on developments from CHEST and CMS."

----------

Genedrive PLC - Manchester, England-based molecular diagnostics firm - Updates on launch of MT-RNR1 assay which detects antibiotic-induced hearing loss. Says large scale trial of product used in 750 newborns in hospitals in Manchester and Liverpool was completed in November 2020. Genedrive adds: "The results of this innovative trial have now been submitted by the study team for publication. Extensive feedback was taken from over 150 nurses who performed AIHL testing over the trial period and this has resulted in a number of refinements being made to the Genedrive unit design principally to further enhance usability in a NICU setting." Genedrive says improvements have been made to interface and data management of product. Genedrive adds: "The company will be seeking CE mark clearance for the new Genedrive system in the coming weeks prior to commercial launch."

----------

Verici Dx PLC - Cardiff-based firm developing and commercialising tests of response to organ transplant, initially focused on kidney transplants - Says patient enrolment for its lead products concludes ahead of management expectations. Company adds: "Early completion of enrolment supports that the company remains on track to complete the validation study for these products by the end of 2021, in line with expectations set out in the company's admission document."

----------

Oxford BioDynamics PLC - Oxford, England-based biotechnology company - Afforded US Foundation for the National Institutes of Health grant for EpiSwitch diagnostic platform. Grant is worth USD910,000. The platform is able to predict a patient's response to immune checkpoint inhibitors, a type of immunotherapy drug. Company adds: "In Q4 2021, OBD expects to launch the 'EpiSwitch ICI Response Test' as a laboratory developed test to allow access for oncologists who want to use it immediately and to start shaping the market."

----------

Sealand Capital Galaxy Ltd - financial and strategic support provider to entrepreneurs - Lands distribution pact with ITP Bulgaria Ltd. Sealand will be sole distributor of ITP's Living Garden Honey brand in Hong Kong, Macau, and mainland China.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 May 2023 16:03

Genedrive jumps on draft NICE testing guidance

(Sharecast News) - Point-of-care molecular diagnostics company Genedrive announced on Friday that the UK's National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of CYP2C19 genotyping before administering clopidogrel in the management of ischemic stroke (IS) patients.

Read more
19 May 2023 10:24

Genedrive says NICE committee recommends CYP2C19 for stroke patients

(Alliance News) - Genedrive PLC on Friday said draft guidance from the UK's National Institute for Health & Care Excellence has recommended that CYP2C19 genotyping should be used to manage ischemic stroke patients.

Read more
19 May 2023 10:15

AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
4 May 2023 16:11

UK shareholder meetings calendar - next 7 days

Friday 5 May 
abrdn Smaller Companies Income Trust PLCAGM
Holders Technology PLCAGM
HSBC Holdings PLCAGM
InterContinental Hotels Group PLCAGM
James Fisher & Sons PLCAGM
Man Group PLCAGM
Rightmove PLCAGM
UK Oil & Gas PLCAGM
Monday 8 May 
no events scheduled 
Tuesday 9 May 
Caledonia Mining Corp PLCAGM
Direct Line Insurance Group PLCAGM
Foxtons Group PLCAGM
Hostelworld Group PLCAGM
IWG PLCAGM
Just Group PLCAGM
Midwich Group PLCAGM
Osirium Technologies PLCAGM
Windward LtdAGM
Wednesday 10 May 
abrdn PLCAGM
Antofagasta PLCAGM
Cenkos Securities PLCAGM
Ecora Resources PLCAGM
H&T Group PLCAGM
Harbour Energy PLCAGM
Jupiter Fund Management PLCAGM
Literacy Capital PLCAGM
Luceco PLCAGM
Marshalls PLCAGM
National Express Group PLCAGM
Renewables Infrastructure Group LtdAGM
Rentokil Initial PLCAGM
Seplat Energy PLCAGM
Spirax-Sarco Engineering PLCAGM
TClarke PLCAGM
Thursday 11 May 
88 Energy LtdAGM
Cairn Homes PLCAGM
Capita PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Eleco PLCAGM
Eurocell PLCAGM
FBD Holdings PLCAGM
Genedrive PLCGM re Equity Prepayment Facility
Genel Energy PLCAGM
Gresham House PLCAGM
Gym Group PLCAGM
Hiscox LtdAGM
Irish Continental Group PLCAGM
John Wood Group PLCAGM
MyHealthChecked PLCAGM
OSB Group PLCAGM
Poolbeg Pharma PLCAGM
Rolls-Royce Holdings PLCAGM
Serinus Energy PLCAGM
Uniphar PLCAGM
Videndum PLCAGM
WAG Payment Solutions PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Mar 2023 20:33

IN BRIEF: Genedrive sees acceleration of revenue in 2023

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Reports revenue in the six months to December 31 of GBP20,000 compared to nothing a year prior, and an operating loss of GBP2.7 million from GBP2.8 million. Confident that the company will see an acceleration of revenues through 2023 and going forwards. Agrees GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd with an initial drawn amount of GBP2 million, expected to be received in early April. Proceeds will be used towards the commercialisation of the antibiotic induced hearing loss test, Genedrive MT-RNR1 ID Kit and enhancing the Genedrive platform as well as providing additional working capital. Directors believe the facility is the best option available at present.

Read more
30 Mar 2023 11:18

Genedrive MT-RNR1 ID kit receives final UK NICE recommendation for NHS

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence ratified and finalised its recommendation that Genedrive's hearing loss gene screening test MT-RNR1 ID kit can be used by the NHS.

Read more
30 Mar 2023 07:57

LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance

(Alliance News) - Stocks in London are set to build on Wednesday's gains, as risk appetite recovers following the recent banking turmoil.

Read more
20 Mar 2023 09:37

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Mar 2023 09:21

Genedrive to roll out hearing loss screening in two NHS sites

(Alliance News) - Genedrive PLC on Monday reported further progress in the rollout of its hearing loss gene screening test in the UK.

Read more
20 Mar 2023 08:53

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

Read more
9 Feb 2023 12:05

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered.

Read more
9 Feb 2023 11:19

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
9 Feb 2023 10:36

Genedrive hearing loss test recommended by UK health department body

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit.

Read more
9 Feb 2023 09:13

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.

Read more
3 Feb 2023 10:26

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.